Joanne M. Langley - Publications, H-index & Citations

Joanne M. Langley

Hospital Universitario La Paz

64H指数

412论文数

1.4W被引数

收录论文 128

发表时间

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study 一种试验性mRNA-脂质纳米颗粒为基础的单价流感疫苗的安全性和免疫原性：来自一项1期、随机、剂量递增研究的结果

Human Vaccines & Immunotherapeutics

IF0

2026-05-23

PREAI

Leroux-Roels, Isabel; De Coster, Ilse; Borobia, Alberto M.; Langley, Joanne M.; Ochoa Mazarro, Dolores; Ruiz-Antoran, Belen; Berre, Stefano; Germain, Sophie; Knauer, Christine; Koch, Sven D.; Mann, Philipp; Mesia Vela, Doris; Ovbude, Leroy Jide; Pardo, Iris Alessandra; Srivastava, Barkha; Moldt, Brian; Nordgren, Marcus

Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada 加拿大婴儿新呼吸道合胞病毒预防疗法的父母可接受性：一项横断面调查

Human Vaccines & Immunotherapeutics

IF0

2026-05-23

PREAI

Fitzpatrick, Tiffany; Parsons Leigh, Jeanna; Brundin-Mather, Rebecca; MacDonald, Jade; Blanchard, Wade; Bolotin, Shelly; Buchan, Sarah A.; Brousseau, Nicholas; Castillo, Eliana; Comeau, Jeannette L.; Dube, Eve; Greyson, Devon; Halperin, Scott A.; Langley, Joanne M.; Lee, Janet S. W.; MacDonald, Shannon E.; Manca, Terra; Moss, Stephana Julia; Papenburg, Jesse; Vadlamudi, Nirma Khatri; Halperin, Donna

Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans 改进的vsv-ebola-GP加强疫苗接种方法可促进人类抗体亲和力成熟和持久的抗埃博拉免疫力

Nature Immunology

IF27.6

2026-03-19

OAAI

Surender Khurana; Olivia Posadas; Lela Kardava; Elizabeth M. Coyle; Supriya Ravichandran; Gabrielle Grubbs; Rosemary McConnell; Nadine Rouphael; Guillaume Poliquin; Joanne M. Langley; Eric Chu; Dean A. Follmann; Xiaoran Shang; Yuxing Li; Susan Moir; Richard T. Davey

Healthcare costs and resource utilization for acute respiratory syncytial virus pediatric hospitalizations in Canada: a population-based study 加拿大急性呼吸道合胞病毒儿科住院患者的医疗费用和资源利用：一项基于人群的研究

The Lancet Regional Health - Americas

IF0

2025-10-06

OAAI

Nirma Khatri Vadlamudi; Kyle Gomes; Ethan Chow; Malou Bourdeau; Joanne Embree; Scott A. Halperin; Taj Jadavji; Kescha Kazmi; Joanne M. Langley; Nicole Le Saux; Dorothy Moore; Shaun K. Morris; Jeffrey M. Pernica; Joan Robinson; Manish Sadarangani; Julie A. Bettinger

Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas 通过疫苗接种预防美洲地区幼儿侵袭性脑膜炎球菌病的必要性

Vaccines 2025, Vol. 13, Page 974

IF3.4

2025-09-29

OAAI

Gaurav Mathur; Joseph B. Domachowske; Maria Gabriela Graña; Reena Ladak; Joanne M. Langley; Oluwatosin Olaiya; Alysa Pompeo; Laura Taddei; Rodolfo Villena

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial COVAC-2的安全性及免疫原性研究，该疫苗为一种基于Sepivac SWE™佐剂的SARS-CoV-2重组蛋白疫苗，研究对象为健康成人；这是一项随机对照的首个人体剂量递增试验。

Vaccine

IF3.5

2025-09-16

PREAI

Glenn Hamonic; Elodie Pastural; Supriya Arora; Jocelyne Lew; Yun Cai; Erin Scruten; Rachelle Buchanan; May ElSherif; Lingyun Ye; Thomas Courant; Roland A. Ventura; Nicolas Collin; Matthieu Daugan; Luc Gagnon; Paul Hodgson; Sylvia van Drunen Little-van den Hurk; Darryl Falzarano; Steve Sanche; Scott A. Halperin; Joanne M. Langley; Volker Gerdts; Trina Racine

Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023 SARS-CoV-2感染的加拿大医疗保健工作者队列风险因素：2020-2023

EPIDEMIOLOGY & INFECTION

IF2.2

2025-06-23

OAAI

Coleman, Brenda L.; Robertson, Nicole M.; Harrison, Robyn A.; Valiquette, Louis; Langley, Joanne M.; Muller, Matthew P.; Cooper, Curtis L.; Nadarajah, Jeya; Powis, Jeff; Arnoldo, Saranya; Smieja, Marek; Vanderkooi, Otto G.; Qi, Freda; Colwill, Karen; Gingras, Anne Claude; McGeer, Allison

Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial AS01E佐剂呼吸道合胞病毒前融合F蛋白疫苗（RSVPreF3 OA）在老年人群中的有效性、安全性和免疫原性研究（跨越三个呼吸道合胞病毒流行季）（AReSVi-006）：一项多中心、随机、观察者设盲、安慰剂对照的III期临床试验

The Lancet Respiratory Medicine

IF0

2025-04-14

PREAI

Michael G Ison; Alberto Papi; Eugene Athan; Robert G Feldman; Joanne M Langley; Dong-Gun Lee; Isabel Leroux-Roels; Federico Martinon-Torres; Tino F Schwarz; Richard N van Zyl-Smit; Susanna Cuadripani; Quentin Deraedt; Nancy Dezutter; Catherine Gerard; Laurence Fissette; Stebin Xavier; Marie-Pierre David; Aurélie Olivier; Marie Van der Wielen; Dominique Descamps; Manuel Zocco

Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis 疾病严重程度，年龄，性别，合并症和疫苗接种对SARS-CoV-2二次发作率的影响: 全球系统回顾和荟萃分析

BMC INFECTIOUS DISEASES

IF3

2025-02-13

OAAI

Sumsuzzman, Dewan Md.; Ye, Yang; Wang, Zhen; Pandey, Abhishek; Langley, Joanne M.; Galvani, Alison P.; Moghadas, Seyed M.

Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine 基于F蛋白的研究性母体呼吸道合胞病毒疫苗的功效，免疫原性和安全性

CLINICAL INFECTIOUS DISEASES

IF7.3

2025-01-29

PREAI

Banooni, Peyman; Gonik, Bernard; Epalza, Cristina; Reyes, Osvaldo; Madhi, Shabir A.; Gomez-Go, Grace Devota; Zaman, Khalequ; Llapur, Conrado Juan; Lopez-Medina, Eduardo; Stanley, Thorsten; Kantele, Anu; Huang, Li-Min; Mussi-Pinhata, Marisa Marcia; Dewulf, Jonas; Langley, Joanne M.; Seidl, Claudia; Ota, Martin; Kirabo, Martha; Anspach, Bruno; Dieussaert, Ilse; Henry, Ouzama; Kim, Joon Hyung; Picciolato, Marta; InvestiGational RSV mAternal vacCinE GRACE Study Grp

Respiratory syncytial virus vaccination during pregnancy

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-11-24

OAAI

Abu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal

Nirsevimab to reduce childhood morbidity caused by respiratory syncytial virus

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-11-24

OAAI

Abu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal

4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults 4CMenB免疫反应，免疫原性和安全性的广度: 来自青少年和年轻人的3期随机，对照，观察者盲法研究的结果

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-10-30

OAAI

Nolan, Terry; Bhusal, Chiranjiwi; Beran, Jiri; Bloch, Mark; Cetin, Benhur S.; Dinleyici, Ener C.; Drazan, Daniel; Kokko, Satu; Koski, Susanna; Laajalahti, Outi; Langley, Joanne M.; Ramet, Mika; Richmond, Peter C.; Silas, Peter; Tapiero, Bruce; Tiong, Florence; Tipton, Mary; Ukkonen, Benita; Ulukol, Betul; Lattanzi, Maria; Trapani, Mauro; Willemsen, Arnold; Toneatto, Daniela

Nirsevimab to reduce infant morbidity from respiratory syncytial virus

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-09-30

OAAI

Abu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal

Respiratory syncytial virus vaccination in pregnancy

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-09-30

OAAI

Abu-Raya, Bahaa; Langley, Joanne M.; Lavoie, Pascal

A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months 1/2a期研究评估Ad26.RSV的安全性和免疫原性。在12-24个月的RSV血清阴性幼儿中的preF

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-08-08

OAAI

Langley, Joanne M.; Nolan, Terry M.; Ramet, Mika; Richmond, Peter C.; Rosario Filho, Nelson; Haazen, Wouter; van den Berg, Sara P. H.; Williams, Kristi; Bastian, Arangassery Rosemary; Omoruyi, Edmund; Durkin, Joanna Williams; Salisch, Nadine; Van Geet, Gunter; van Duijnhoven, Wilbert; Heijnen, Esther; Callendret, Benoit

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons 呼吸道合胞病毒 (RSV) 融合F蛋白疫苗 (RSVPreF3 OA) 在2个RSV季节的老年人中的功效和安全性

CLINICAL INFECTIOUS DISEASES

IF7.3

2024-01-22

OAAI

Ison, Michael G.; Papi, Alberto; Athan, Eugene; Feldman, Robert G.; Langley, Joanne M.; Lee, Dong-Gun; Leroux-Roels, Isabel; Martinon-Torres, Federico; Schwarz, Tino F.; van Zyl-Smit, Richard N.; Verheust, Celine; Dezutter, Nancy; Gruselle, Olivier; Fissette, Laurence; David, Marie-Pierre; Kostanyan, Lusine; Hulstrom, Veronica; Olivier, Aurelie; van der Wielen, Marie; Descamps, Dominique

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study

LANCET REGIONAL HEALTH-AMERICAS

IF7.6

2023-12-01

OAAI

Shoukat, Affan; Abdollahi, Elaheh; Galvani, Alison P.; Halperin, Scott A.; Langley, Joanne M.; Moghadas, Seyed M.

Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States 基于Prefusion F蛋白的疫苗在美国针对老年人的呼吸道合胞病毒疾病的成本效益

CLINICAL INFECTIOUS DISEASES

IF7.3

2023-11-30

OAAI

Moghadas, Seyed M.; Shoukat, Affan; Bawden, Carolyn E.; Langley, Joanne M.; Singer, Burton H.; Fitzpatrick, Meagan C.; Galvani, Alison P.